Rebecca "Becky" Wood, a product liability litigator and former Sidley Austin partner, is the new top lawyer at the US FDA.
FDA Commissioner Scott Gottlieb announced the appointment of Wood to the chief counsel's post in a July 11 all-hands email....
Former Sidley Austin partner brings a wealth of experience in drug product liability litigation and federal preemption. She replaces agency veteran Elizabeth Dickinson, who will stay on as senior deputy to the chief counsel.
Rebecca "Becky" Wood, a product liability litigator and former Sidley Austin partner, is the new top lawyer at the US FDA.
FDA Commissioner Scott Gottlieb announced the appointment of Wood to the chief counsel's post in a July 11 all-hands email....
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.